ArticleAnnals of medicine and surgery (2012)2026
Single-incision robotic surgery: the emerging milestone in minimally invasive practice.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Single-incision robotic surgery (SIRS) has emerged as a progression in minimally invasive practice, enabling complex operations through a single entry point. Modern systems such as the da Vinci SP (Intuitive Surgical, USA) and Versius (CMR Surgical, UK) allow multi-instrument articulation and high-definition visualization through a single port, overcoming the ergonomic and triangulation challenges of traditional laparoscopy. Recent evidence from South Korea, China, the USA, and Turkey demonstrates SIRS's feasibility, safety, and promising clinical outcomes across specialties including urology, gynecology, and general surgery. Studies report lower conversion rates, minimal postoperative pain, and enhanced cosmesis, though cost and learning curve remain limiting factors. As robotic technologies evolve, SIRS is poised to redefine minimally invasive standards through precision, reduced invasiveness, and improved recovery profiles. Rigorous multicenter trials and cost-effectiveness analyses are essential to confirm its broader clinical value.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.